Company & Sponsor Intelligence
University of Delaware
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed3
Countries1
Therapeutic footprint
adhdparkinsons
Indexed studies
NCT02093052Intervening Early With Neglected Children
adhd · United StatesPHASE1, PHASE2
adhd · United StatesPHASE1, PHASE2
NCT06829342Stochastic Resonance Stimulation Effect on Gait Stability in Parkinson Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT04904068Functional Neuroimaging in Parkinson's Disease
parkinsons · United StatesCOMPLETED
parkinsons · United StatesCOMPLETED
NCT00056303Mental Health Services for Foster and Adopted Children
adhd · United StatesPHASE1
adhd · United StatesPHASE1
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →